StockData
Moderna, Inc. logo

Moderna, Inc.

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 5/30567% above fair value
$220.83−0.89 (-0.40%)

Close on Nov 2, 2026Market cap $88.16BP/E –Yield –

Moderna Capital expenditures by Quarter

Capital expenditures — Purchases of property and equipment ($M) ($M)

QuarterlyAnnual

Moderna Capital expenditures: $37M in Q2 2026, up 1,133.3% from a year earlier.

Latest, Q2 2026
37
Period ended Jun 30, 2026
Change on a year earlier
+1,133.3%
3 in Q2 2025
History
34 quarters
Since Q1 2018
Sources
28
Documents cited below

Where the Q2 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: Form 10-Q (filed 2026-07-31) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Cash Flows.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCapital expenditures — Purchases of property and equipment ($M) ($M)Year on yearSource
Q2 2026Jun 30, 202637+1,133.3%Form 10-Q (filed 2026-07-31) ↗
Q1 2026Mar 31, 202662-47.0%Form 10-Q (filed 2026-05-01) ↗
Q4 2025Dec 31, 202539-92.5%Form 10-K (filed 2026-02-20) ↗
Q3 2025Sep 30, 202533-78.1%Form 10-Q (filed 2025-11-06) ↗
Q2 2025Jun 30, 20253-98.4%Form 10-Q (filed 2026-07-31) ↗
Q1 2025Mar 31, 2025117-40.3%Form 10-Q (filed 2026-05-01) ↗
Q4 2024Dec 31, 2024522+137.3%Form 10-K (filed 2026-02-20) ↗
Q3 2024Sep 30, 2024151+7.9%Form 10-Q (filed 2025-11-06) ↗
Q2 2024Jun 30, 2024182-22.2%Form 10-Q (filed 2025-08-01) ↗
Q1 2024Mar 31, 2024196+73.5%Form 10-Q (filed 2025-05-01) ↗
Q4 2023Dec 31, 2023220+139.1%Form 10-K (filed 2026-02-20) ↗
Q3 2023Sep 30, 2023140+57.3%Form 10-Q (filed 2024-11-07) ↗
Q2 2023Jun 30, 2023234+169.0%Form 10-Q (filed 2024-08-01) ↗
Q1 2023Mar 31, 2023113-14.4%Form 10-Q (filed 2024-05-02) ↗
Q4 2022Dec 31, 202292-23.3%Form 10-K (filed 2025-02-21) ↗
Q3 2022Sep 30, 202289-10.1%Form 10-Q (filed 2023-11-03) ↗

Cite this data

StockData. (2026). Moderna Capital expenditures ($M), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/capex-cash-xbrl

See every metric in the Moderna KPI table. Data updated Nov 3, 2026.